Healthcare Industry News: kyphoplasty
News Release - April 17, 2007
Spine Wave Receives FDA Clearance for CapSure(TM) PS Pedicle Screw SystemU.S. Sales Force Expansion Underway to Support Product Portfolio
SHELTON, CT--(Healthcare Sales & Marketing Network)--Apr 17, 2007 -- Spine Wave, Inc., a company that develops and markets innovative spinal surgical solutions, announced it has received FDA 510(k) clearance to market its CapSure(TM) PS Spine System. The CapSure(TM) PS pedicle screw system will complement the Company's StaXx® XD expandable PEEK spacer, which has also received 510(k) clearance. The Company is initiating a limited release of the CapSure(TM) PS System during the second quarter of 2007 and anticipates a broader market release of both products by the end of 2007.
"With three new products and a recently announced $45 million financing, we can aggressively pursue rapid sales team expansion," said Nick Lake. "Our goal is to build a strong, technically oriented sales team that provides first class customer service."
About Spine Wave, Inc.
Spine Wave, headquartered in Shelton, Connecticut, is focused on the development of clinical solutions for three of the largest and fastest growing spinal market segments: nuclear replacement and augmentation, vertebral compression fracture repair and spinal fusion. The Company's product portfolio includes the NuCore(TM) Injectable Nucleus, the StaXx® FX Structural kyphoplasty System, the StaXx® XD Expandable Device, the CapSure(TM) PS Spine System and several additional products in development. For further information, visit the Company's website at www.SpineWave.com.
Source: Spine Wave
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.